Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50

Am J Pathol. 2012 Nov;181(5):1530-9. doi: 10.1016/j.ajpath.2012.07.024. Epub 2012 Aug 30.

Abstract

Current animal models of chronic intermittent hypoxia (CIH)-induced atherosclerosis have limitations. Mechanisms of CIH-induced atherosclerosis are poorly understood. This study tested new mouse models of CIH-induced atherosclerosis and defined the role of NF-κB p50 in CIH-induced atherosclerosis. Mice deficient in apolipoprotein E (ApoE-KO) or in both ApoE and p50 genes (ApoE-p50-DKO) were exposed to sham or CIH. Atherosclerotic lesions on aortic preparations were analyzed. CIH exposure caused atherosclerosis in ApoE-KO mice fed a normal chow diet and with no preexisting atherosclerotic condition in an exposure time-dependent manner. CIH caused more pronounced atherosclerotic lesions in ApoE-p50-DKO mice on a normal chow diet without preexisting atherosclerosis. ApoE-KO and ApoE-p50-DKO mice exposed to CIH for 30 and 9 weeks, respectively, displayed similar areas of atherosclerotic lesions on cross sections of aortic root. P50 gene deletion in ApoE-p50-DKO mice significantly augmented CIH-induced serum levels of tumor necrosis factor-α and IL-6, aortic tumor necrosis factor-α, and inducible nitric oxide synthase expression and aortic infiltration of Mac3-positive macrophages. CIH caused a greater elevation in serum cholesterol level in ApoE-p50-DKO than in ApoE-KO mice. CIH down-regulated hepatic low-density lipoprotein receptor and HMG-CoA reductase expression in ApoE-p50-DKO but not in ApoE-KO mice. We found two new mouse models that are useful for studying mechanisms and pathways of CIH-induced atherosclerosis. We showed that NF-κB p50 protects against CIH-induced atherosclerosis by inhibiting vascular inflammation and hypercholesterolemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / enzymology
  • Aorta / pathology
  • Apolipoproteins E / deficiency*
  • Apolipoproteins E / metabolism
  • Atherosclerosis / blood
  • Atherosclerosis / complications
  • Atherosclerosis / metabolism*
  • Atherosclerosis / pathology*
  • Body Weight
  • Cholesterol / blood
  • Chronic Disease
  • Down-Regulation
  • Female
  • Gene Deletion
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / metabolism
  • Hypercholesterolemia / pathology
  • Hypoxia / blood
  • Hypoxia / complications
  • Hypoxia / metabolism*
  • Hypoxia / pathology*
  • Inflammation / blood
  • Inflammation / complications
  • Inflammation / metabolism
  • Inflammation / pathology
  • Male
  • Mice
  • Mice, Knockout
  • NF-kappa B p50 Subunit / metabolism*
  • Nitric Oxide Synthase Type II
  • Oxygen
  • Receptors, LDL / metabolism
  • Signal Transduction
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Apolipoproteins E
  • NF-kappa B p50 Subunit
  • Receptors, LDL
  • Tumor Necrosis Factor-alpha
  • Cholesterol
  • Nitric Oxide Synthase Type II
  • Oxygen